Cargando…

Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI‐NHR risk model

BACKGROUND: The currently available mortality prediction models (MPM) have suboptimal performance when predicting early mortality (30‐days) following transcatheter aortic valve implantation (TAVI) on various external populations. We developed and validated a new TAVI‐MPM based on a large number of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al‐Farra, Hatem, Ravelli, Anita C. J., Henriques, José P. S., Houterman, Saskia, de Mol, Bas A. J. M., Abu‐Hanna, Ameen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Valvular and Structural Heart Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826169/ https://www.ncbi.nlm.nih.gov/pubmed/36069120 http://dx.doi.org/10.1002/ccd.30398

Ejemplares similares

Update and, internal and temporal-validation of the FRANCE-2 and ACC-TAVI early-mortality prediction models for Transcatheter Aortic Valve Implantation (TAVI) using data from the Netherlands heart registration (NHR)
por: Al-Farra, Hatem, et al.
Publicado: (2021)

Impact of social deprivation on outcome following transcatheter aortic valve implantation (TAVI)
por: Mohee, Kevin, et al.
Publicado: (2019)

Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry
por: Saito, Tetsuya, et al.
Publicado: (2020)

Mass to voltage ratio index predicts mortality following TAVI
por: Porat, Alon, et al.
Publicado: (2022)

Time to TAVI: streamlining the pathway to treatment
por: Hewitson, Lynsey Jane, et al.
Publicado: (2023)

Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis
por: Khawaja, M Z, et al.
Publicado: (2014)

Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)
por: Lutz, Matthias, et al.
Publicado: (2017)

Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry
por: Enta, Yusuke, et al.
Publicado: (2020)

Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI
por: Venturi, Gabriele, et al.
Publicado: (2022)

Incidence and Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Procedures: Data of The Netherlands Heart Registration (NHR)
por: Ravaux, Justine M., et al.
Publicado: (2022)

Results and insights after 413 TAVI procedures performed by cardiac surgeons on their own
por: Malvindi, Pietro Giorgio, et al.
Publicado: (2023)

Severe symptomatic aortic stenosis: medical therapy and transcatheter aortic valve implantation (TAVI)—a real-world retrospective cohort analysis of outcomes and cost-effectiveness using national data
por: Freeman, Phillip M, et al.
Publicado: (2016)

Trial protocol for the validation of the ‘Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire’ in patients undergoing surgical aortic valve replacement (SAVR) or transfemoral (TF) transcatheter aortic valve implantation (TAVI): the TASQ registry
por: Frank, Derk, et al.
Publicado: (2019)

Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice
por: Lauten, Alexander, et al.
Publicado: (2021)

Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI
por: Ludwig, Sebastian, et al.
Publicado: (2022)

Incidence and predictors of prosthesis–patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve
por: Miyasaka, Masaki, et al.
Publicado: (2021)

Utility of conventional aortic root shot angiography for SAPIEN 3 prosthesis sizing in TAVI: feasibility and inter-reader variability
por: Gansera, Laura, et al.
Publicado: (2019)

Clinical value of the 20% logistic EuroSCORE cut-off for selecting TAVI candidates: a single-centre cohort study analysis
por: Imnadze, Guram, et al.
Publicado: (2020)

Incidence and predictors of permanent pacemaker implantation after surgical aortic v alve replacement: Data of the Netherlands Heart Registration (NHR)
por: Ravaux, Justine M., et al.
Publicado: (2021)

Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement
por: Yamamoto, Masanori, et al.
Publicado: (2020)

Cerebral Embolic Protection in TAVI: Friend or Foe
por: Teitelbaum, Michael, et al.
Publicado: (2019)

How to Make the TAVI Pathway More Efficient
por: Tchetche, Didier, et al.
Publicado: (2019)

TAVI for Pure Native Aortic Regurgitation: Are We There Yet?
por: Arias, Eduardo A, et al.
Publicado: (2019)

Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
por: Goldsweig, Andrew M., et al.
Publicado: (2022)

A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)

Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement
por: Isogai, Toshiaki, et al.
Publicado: (2022)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome
por: Meijerink, Frank, et al.
Publicado: (2021)

Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes
por: Corcione, Nicola, et al.
Publicado: (2022)

Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation
por: Asami, Masahiko, et al.
Publicado: (2022)

Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex
por: Yong, Celina M., et al.
Publicado: (2022)

Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair
por: Miller, Matthew S., et al.
Publicado: (2022)

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
por: Liu, Xianbao, et al.
Publicado: (2018)

Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

SAPIEN 3 transcatheter heart valve in patients with borderline annulus: “stretched better than bigger?”
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

TAVI-in-TAVI — Is this the future?
por: Jedrzejczyk, Szymon, et al.
Publicado: (2019)

Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program
por: Hokken, Thijmen W., et al.
Publicado: (2021)

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
por: Liu, Xianbao, et al.
Publicado: (2021)

Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry
por: Moriyama, Noriaki, et al.
Publicado: (2020)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3e06mhirfgpqrdjcjibn2pps9v